Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

The Corporate Reputation of Pharma Companies, 2016: Perspective of 98 Latin-American Patient Groups (2017 Edition) - Research and Markets

Research and Markets
Posted on: 27 Oct 17

The "The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 98 Latin-American Patient Groups (2nd Edition)" report has been added to Research and Markets' offering.

These results are derived from a global review of pharma's corporate reputation (conducted November 2016 to early-February 2017).

This report is based on the opinions of 98 Latin-American patient groups, from Argentina (10), Bolivia (2), Brazil (21), Chile (8), Colombia (8), Costa Rica (6), Cuba (1), the Dominican Republic (1), Ecudaor (2), Guatemala (2), Mexico (27), Panama (1), Peru (2), Uruguay (1), Venezuela (4).

20 specialised in cancer; 9 in neurological conditions; 7 in haemophilia; and other specialties.

15 pharma companies are included in this 2016 Latin-America analysis:

  • AbbVie
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly (Lilly)
  • GSK
  • Janssen (Pharmaceutical companies of Johnson & Johnson)
  • Merck & Co
  • Novartis
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • Teva

For more information about this report visit https://www.researchandmarkets.com/research/6qxtw7/the_corporate

View source version on businesswire.com: http://www.businesswire.com/news/home/20171027005264/en/

Business Wire
www.businesswire.com

Last updated on: 27/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.